Skip to main content
. 2021 Dec 16;3:673452. doi: 10.3389/fspor.2021.673452

Table 4.

Evaluation of the methodological quality of the studies considered to assess the risk of bias (based on Schulz et al., 2010; Pluye et al., 2011).

Author(s) 1 2 3 4 5 6 7 8 9 10 11 Sum % Score
Barkoukis et al. (2016) Y Y Y Y N Y Y Y P N N 7.5 68 ***
Codella et al. (2019) Y Y P N N N N N Y N Y 4.5 41 **
Duncan and Hallward (2019) Y Y Y P N Y Y Y P Y Y 9 82 ****
Elbe and Brand (2016) Y Y Y P N Y Y Y P P Y 8.5 77 ****
Elliot et al. (2008) P Y Y P N N Y Y P N N 5.5 50 **
Elliot et al. (2006) → (see Elliot et al., 2004)
Elliot et al. (2004) N Y Y P N Y Y Y N N N 5.5 50 **
Goldberg et al. (2000) → (see Goldberg et al., 1996a)
Goldberg et al. (1996a) Y P Y P N Y P Y P P N 6.5 59 ***
Goldberg et al. (1996b) Y Y Y P N N P P P N N 5 45 **
Goldberg et al. (1991) N Y P N N N P Y P N N 3.5 32 **
Goldberg et al. (1990) N Y Y P N N Y Y P N N 5 45 **
Halliburton and Fritz (2018) P Y N P N N P Y Y Y Y 6.5 59 ***
Horcajo et al. (2019) Y Y Y Y Y N Y Y Y Y Y 10 90 ****
Horcajo and de la Vega (2014) Y Y Y Y N Y P Y Y P N 8 73 ***
Hurst et al. (2020) Y P Y Y N P Y N P N Y 6 54 ***
Jalilian et al. (2011) Y P P Y N N P Y N N Y 5.5 50 **
Laure et al. (2009) Y Y Y P N N Y Y Y P N 7 63 ***
Lucidi et al. (2017) Y Y Y N N Y Y N Y P Y 7 63 ***
MacKinnon et al. (2001) Y Y P Y N Y P Y Y P N 7.5 68 ***
Mallia et al. (2020) Y Y Y Y N P N N Y P Y 7 63 ***
Medina et al. (2019) P Y Y N N N P N P N N 3 27 **
Nicholls et al. (2020) Y Y Y Y N P Y Y Y N Y 8.5 77 ****
Nilsson et al. (2004) Y Y P P N N Y N N N N 4 36 **
Ntoumanis et al. (2020) Y Y Y Y Y N Y Y Y N Y 9 81 ****
Ranby et al. (2009) Y Y Y P N Y Y Y Y P Y 8 73 ***
Sagoe et al. (2016) Y Y P Y N N Y Y P N N 6 54 ***
Wicki et al. (2018) Y Y N P N N P N Y N N 4 36 **
Wippert and Fließer (2016) P Y N N P N P N N N Y 3.5 32 **
Yager et al. (2019) Y Y Y Y N N P Y P Y N 6.5 59 ***

1: [Introduction] Scientific background and explanation of rationale. Y, precise scientific background; P, brief overview; N, not specified.

2: [Introduction] Specification of a research question, specific objectives and/or hypotheses. Y, yes; P, implied; N, not specified.

3: [Methods] Information concerning the intervention (especially regarding: content, implementation, transparency/sufficient details for replication. Y, yes; P, implied; N, not specified.

4: [Methods] Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed; fit of collected data and research question. Y, measures specified beforehand, validated and reliable (Cronbach's alpha > 0.80); P, measure specified beforehand, but weaknesses concerning measures applied (e.g., single-item, Cronbach's alpha <0.80); N, measures not specified appropriately, regardless of the quality of the measure used.

5: [Methods] Determination of the sample size before conducting the study. Y, yes; N, not specified.

6: [Methods] Minimization of a selection bias in the recruitment of participants. Y, indication of why the selected sample is considered representative; P, sample representative with limitations; N, not reported or disregarded.

7: [Methods] Representativeness of the participants with regard to study goal. Y, yes; P, partly; N, no;.

8: [Methods] Information about sample composition, e.g., randomization. Y, yes; N, no.

9: [Results] Statistical methods used to compare groups for primary and secondary outcomes, completeness of information (e.g., checking for distribution violation before using metric procedures). Y, yes; P, partly; N, no.

10 [Results/Discussion] Significance of results/limits, e.g., low drop-out below 20%. Y, yes; P, partly; N, no or lack of report.

11 [Acknowledgments] Conflict of interest. Y, no conflict of interest/criterion met, N, conflict of interest (incl. reviewed conflict of interest) or not specified/criterion not met.

Score:

*

(lowest quality),

**, ***, ****

(highest quality).

HHS Vulnerability Disclosure